http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002173502-A1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
filingDate | 2002-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3d3ef534b186b80bffc31ee65d99ed8 |
publicationDate | 2002-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-2002173502-A1 |
titleOfInvention | Pharmaceutically active compounds |
abstract | There is provided a general formula I: n n n or a pharmaceutically or veterinarily acceptable salt or polymorph and/or solvate thereof, wherein n R 1 represents H; C(O)C 1 -C 4 alkyl; C(O)aryl; C(O)heteroaryl. n and which is useful in the curative and prophylactic treatment of a medical condition for which inhibition of a cyclic guanosine 3′,5′-monophosphate phosphodiesterase (and in particular cGMP PDE5) is desired. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6756373-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004077650-A1 |
priorityDate | 2001-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1019.